Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 964-970

  Pujol, J L ^a   Simony, J ^b   Jolimoy, G ^a   Jaffuel, D ^a   Demoly, P ^a   Quantin, X ^a   Marty Ane C ^a   Boher, J M ^c   Charpentier, R ^d   Michel, F B ^a  

^a UNIV MONTPELLIER   (France)

^b CENTRE VAL D AURELLE   (France)

^c Centre Hospitalier Régional   (France)

^d Clinique de Chirurgie Thoracique   (France)

Author keywords

Growth fraction; Ki 67; Lung cancer; Ploidy; Prognosis; Surgery

Indexed keywords

CELL DNA; CELL NUCLEUS ANTIGEN; MONOCLONAL ANTIBODY KI 67; SCHIFF BASE;

ADULT; AGED; ARTICLE; CANCER STATISTICS; CELL CYCLE; CLINICAL TRIAL; DIPLOIDY; DNA CONTENT; FEMALE; FEULGEN STAINING; HISTOGRAM; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 10144220641     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.466     Document Type: Article

References (33)

1. ABE S, MAKIMURA S, ITABASHI K, NAGAI T, TSUNETA Y AND KAWAKAMI Y. (1985). Prognostic significance of nuclear DNA content in small cell carcinoma of the lung. Cancer, 56, 2025-2030.
2. BACUS JW AND GRACE LJ. (1987). Optical microscopic system for standardized cell measurements and analyses. Appl. Opt., 26, 3280-3293.
3. BARLOGIE B, DREWINKO B, SCHUMANN J, GÖHDK W, DOSIK G, LATRIELLE J, JOHNSTON DA AND FREIREICH EJ. (1980). Cellular DNA content as a marker of neoplasia in man. Am. J. Med., 69, 195-203.
4. BARLOGIE B, RABER MN, SHUMANN J, JOHNSON TS, DRRWINKI B, SWARTZENDRUBER DE, GÖHDE W, ANDREEFF M AND FEIREICH EJ. (1983). Flow cytometry in clinical cancer research. Cancer Res., 43, 3982-3997.
5. BLÖNDAL T AND BENGTSSON A. (1981). Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation. Anticancer Res., 1, 79-86.
6. BUNN PA, CARNEY DN, GAZDAR AF, WHANG-PENG J AND MATTHEWS MJ. (1983). Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res., 43, 5026-5032.
7. CHARPIN C, MARTIN PM, JACQUEMIN J, LAVAUT MN, POURREAU-SCHNEIDER N AND TOGA M. (1986). Estrogen receptor immunohistochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy and comparisons with estradiol binding assays in 115 breast carcinomas. Cancer Res., 46, 4271-4277.
8. CHEON SH, SOHN HY, CHANG J, KIM SK, KO EH, KIMM SK, LEE WY, LEE DY, SHO DH, JEONG ET AND CHUNG HT. (1993). Flow cytometric analysis of DNA ploidy in primary non-small cell carcinoma of the lung in Korea. Yonsei Med. J., 34, 365-370.
9. CIBAS ES, MELAMED MR, ZAMAN MB AND KIMMEL M. (1989). The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung. Cancer, 63, 1552-1556.
10. COULSON BP, THORNTHWAITE JT, WEELLEY TW, SUGARBAKER EV AND SECKINGER D. (1984). Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res., 44, 4187-4196.
11. COX DR. (1972). Regression models and life tables. J. R. Stat. Soc. B., 34, 187-202.
12. DAZZI H, THATCHER N, HASLETON PS AND SWINDELL R. (1990). DNA analysis by flow cytometry in non-small cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival. Respir. Med., 84, 217-223.
13. FREIDLANDER ML, HEDLEY DW AND TAYLOR IW. (1984). Clinical and biological significance of aneuploidy in human tumours. J. Clin. Pathol., 37, 961-974.
14. GERDES J, LEMKE H, BAISCH H, WACKER HH, SCHWAB U AND STEIN H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715.
15. GRATZNER HG. (1982). Monoclonal antibody to 5-bromo and 5-iododeoxyuridine. A new reagent for detection of DNA replication. Science, 218, 474-476.
16. HAYASHI Y, FUKAYAMA M, KOIKE M, KASEDA S, IKEDA T AND YOKOYAMA T. (1993). Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU in vivo labelling and application to lung tumors. Acta Pathol. Jpn., 43, 313-319.
17. HSU SM, RAINE L AND FANGER H. (1981). The use of avidin biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580.
18. KAPLAN EL AND MEIER P. (1958). Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457-481.
19. KENJI M, YOSHIKAZU K, SADAMU N AND YOSHIHIRO U. (1971). Automated Feulgen's reaction in autoscreening. J. Jpn. Soc. Clin. Cytol., 10, 148-154.
20. MOUTAIN CF. (1986). A new international staging system for lung cancer. Chest, 4, 225s-233s.
21. OPFERMANN M, BRUGAL G AND VASSILAKOS P. (1987). Cytometry of breast carcinoma: Significance of ploidy balance and proliferation index. Cytometry, 8, 217-224.
22. PENCE JC, KERNS BM, DODGE RK AND IGLEHART JF. (1993). Prognostic significance of the proliferation index in surgically resected non-small cell lung cancer. Arch. Surg., 128, 1382-1390.
23. SALVATI F, TEODORI L, GAGLIARDI L, SIGNORA M, AQUILINI M AND STORNIELLO G. (1988). DNA flow cytometric studies of 666 human lung tumours analyzed before treatment. Chest. 96, 1092-1098.
24. SIMONY J, PUJOL JL, RADAL M, URSULE E, MICHEL FB AND PUJOL H. (1990). In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Cancer Res., 50, 4382-4387.
25. SMITH L, BARLOGIE B AND ALEXANIAN R. (1986). Biolonal and hypodiploid multiple myeloma. Am. J. Med., 80, 841-843.
26. SOBIN LH, HERMANEK P AND HUNTER RVP. (1987). TNM Classification of Malignant Tumours. 4th ed. UICC: Geneva.
27. THEUNISSEN PHMH, LEERS MPG AND BOLLEN ECM. (1992). Proliferating cell nuclear antigen (PCNA) expression in formalinfixed tissue of non-small cell lung carcinoma. Histopathology, 20, 251-255.
28. TISI GM, FRIEDMAN PJ, PETERS RM, PEARSON G, CARR D, LEE RE AND SELAWRY O. (1982). American Thoracic Society: clinical staging of primary lung cancer. Am. Rev. Respir. Dis., 125, 659-664.
29. TUBIANA M AND COURDI A. (1989). Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother. Oncol., 15, 1-18.
30. TUNGEKAR MF, GATTER KC, DUNNILL MS AND MASON DY. (1991). Ki-67 immunostaining and survival in operable lung cancer. Histopathology, 19, 545-550.
31. VOLM, M, DRINGS P, MARRTERN J, SONKA J, VOGT-MOYKOPF I AND WAYSS K. (1985). Prognostic significance of DNA patterns and resistance predictive tests in non-small cell lung carcinoma. Cancer, 56, 1396-1403.
32. WORLD HEALTH ORGANIZATION. (1982). The World Health Organization histological typing of the lung tumors. 2nd ed. Am. J. Clin. Pathol., 77, 123-136.
33. ZIMMERMANN PV, HAWSON GAT, BINT MH AND PARSONS PG. (1987). Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet, 2, 530-533.